Is the Mayne Pharma Group Ltd share price too cheap to ignore?

The Mayne Pharma Group Ltd (ASX:MYX) share price has fallen 52% in the last 12 months. Is it too cheap to ignore?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday the Mayne Pharma Group Ltd (ASX: MYX) share price tumbled lower again, leaving it hovering just half a cent above its 52-week low of 94 cents.

This now means the pharmaceutical company's shares have lost over half of their value since this time last year.

Is it time to pick up shares?

At this stage I think the prudent thing to do is to hold off an investment until Mayne Pharma reports its full-year results on August 25.

Whilst the growing pharmaceutical company could prove to be absolute bargain buy, there is also a danger it could be a value trap.

I believe a lot will ultimately depend on what impact President Trump has on the pharmaceutical industry in the future.

Although he has been quiet on the subject in recent months, Trump's Food and Drug Administration commissioner Scott Gottlieb hasn't been.

Mr Gottlieb told Bloomberg in May that the FDA will change the generic-drug approval process with a focus on lowering prices.

This is especially troubling for Mayne Pharma as last year it spent $890 million to acquire a portfolio of generic drugs from Teva Pharmaceutical Industries and Allergan Plc.

The danger now is that the company may not be able to command the kind of prices for these generic drugs that it had previously modelled, potentially meaning the company significantly overpaid for the acquisition.

What now?

In light of this, I would suggest investors hold off an investment and wait until the company updates the market in August.

In the meantime, investors looking for exposure to the industry may want to consider looking at CSL Limited (ASX: CSL) or Nanosonics Ltd (ASX: NAN) instead.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »